Palisade Bio, Inc.

8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 11, 2026 8-K Results of operations (earnings release) May 12, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Other events Apr 2, 2026 10-K Fiscal year ended 2025-12-31 Mar 20, 2026 8-K Amended charter or bylaws; Shareholder vote results Dec 4, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Director or officer change Oct 22, 2025 8-K Shareholder vote results Oct 20, 2025 8-K Other events Oct 16, 2025 8-K Other events Oct 9, 2025 8-K Other events Sep 26, 2025 8-K Other events Sep 18, 2025 8-K Director or officer change Sep 5, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 25, 2025 8-K Director or officer change; Other events Jul 9, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Delisting notice or listing-rule failure May 2, 2025 10-K Fiscal year ended 2024-12-31 Mar 24, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 16, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Director or officer change Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 12, 2024 8-K Shareholder vote results Jul 8, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Director or officer change; Other events May 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events May 3, 2024 8-K Other events Apr 10, 2024 8-K Amended charter or bylaws; Other events Apr 5, 2024 8-K Results of operations (earnings release); Delisting notice or listing-rule failure; Shareholder vote results Mar 27, 2024 10-K Fiscal year ended 2023-12-31 Mar 26, 2024 8-K Director or officer change; Amended charter or bylaws Mar 6, 2024 8-K Director or officer change; Other events Feb 13, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Feb 1, 2024 8-K Regulation FD disclosure Jan 29, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Regulation FD disclosure Nov 7, 2023 8-K Delisting notice or listing-rule failure Oct 20, 2023 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Other events Sep 11, 2023